Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

8 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Indirect Ophthalmoscopy Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g - Indirect Ophthalmoscopy Screening

- 21/03/2018 - 1 Formulário, 4 Grupos de itens, 48 Elementos de dados, 1 Idioma
Grupos de itens: Indirect Ophthalmoscopy Right Eye, Indirect Ophthalmoscopy Left Eye , Retinal Break or Detachment right eye, Retinal Break or Detachment left eye
Study part: Indirect Ophthalmoscopy Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Indirect Ophthalmoscopy Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Indirect Ophthalmoscopy Screening

- 21/03/2018 - 1 Formulário, 4 Grupos de itens, 48 Elementos de dados, 1 Idioma
Grupos de itens: Indirect Ophthalmoscopy Right Eye, Indirect Ophthalmoscopy Left Eye , Retinal Break or Detachment right eye, Retinal Break or Detachment left eye
Study part: Indirect Ophthalmoscopy Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

INDIRECT OPHTHALMOSCOPY (DAY 7) CRFs Roche FVF4168G Macular Edema NCT00473330

- 11/06/2017 - 1 Formulário, 3 Grupos de itens, 22 Elementos de dados, 1 Idioma
Grupos de itens: Patient administration, INDIRECT OPHTHALMOSCOPY (DAY 7), INDIRECT OPHTHALMOSCOPY (DAY 7)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INDIRECT OPHTHALMOSCOPY (DAY 7) CRFs Roche FVF4170G Macular Edema NCT00473382

- 11/06/2017 - 1 Formulário, 3 Grupos de itens, 22 Elementos de dados, 1 Idioma
Grupos de itens: Patient administration, INDIRECT OPHTHALMOSCOPY (DAY 7), INDIRECT OPHTHALMOSCOPY (DAY 7)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INDIRECT OPHTHALMOSCOPY (DAY 0) CRFs Roche FVF4170G Macular Edema NCT00473382

- 09/06/2017 - 1 Formulário, 3 Grupos de itens, 21 Elementos de dados, 1 Idioma
Grupos de itens: Patient administration, INDIRECT OPHTHALMOSCOPY (DAY 0), INDIRECT OPHTHALMOSCOPY (DAY 0)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INDIRECT OPHTHALMOSCOPY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 08/06/2017 - 1 Formulário, 3 Grupos de itens, 45 Elementos de dados, 1 Idioma
Grupos de itens: Patient administration, INDIRECT OPHTHALMOSCOPY (SCREENING), INDIRECT OPHTHALMOSCOPY (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INDIRECT OPHTHALMOSCOPY (DAY 0) CRFs Roche FVF4168G Macular Edema NCT00473330

- 08/06/2017 - 1 Formulário, 3 Grupos de itens, 21 Elementos de dados, 1 Idioma
Grupos de itens: Patient administration, INDIRECT OPHTHALMOSCOPY (DAY 0), INDIRECT OPHTHALMOSCOPY (DAY 0)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INDIRECT OPHTHALMOSCOPY (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330

- 08/06/2017 - 1 Formulário, 3 Grupos de itens, 45 Elementos de dados, 1 Idioma
Grupos de itens: Patient administration, INDIRECT OPHTHALMOSCOPY (SCREENING), INDIRECT OPHTHALMOSCOPY (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial